Birgitta Lundvik

Directeur Financier/CFO chez ALZECURE PHARMA AB

Profil

Currently, Birgitta Lundvik is Chief Executive Officer & Director at Enable-Finance & Business Development AB since 2018, Chief Executive Officer at Favro Holding AB, Chairman at HERAccount AB, Deputy Director at Helander & Lundvik Ekonomikonsulter AB, Deputy Director at Balanced Competence Uppasala Redovisiningsbyra AB, Deputy Director at Brf Arken, Director at LobSor International AB, Chief Financial Officer at AlzeCure Pharma AB since 2017, and Chief Financial Officer at Newlist AB since 2020.
Former positions include Deputy Chief Executive Officer at Favro AB, Deputy Chief Executive Officer at Nonna Holding AB, Chief Executive Officer & Director at Hansoft Technologies AB, Chairman at Lobsor Pharmaceuticals AB, Deputy Chairman at Swedsoft, Secretary & Treasurer at Favro North America, Inc., and Chief Financial Officer at Sinfonia Biotherapeutics AB from 2018 to 2022.
Education includes a graduate degree from the University of Uppsala and an MBA from Stockholm Business School.

Postes actifs de Birgitta Lundvik

Sociétés	Poste	Début
ALZECURE PHARMA AB	Directeur Financier/CFO	01/01/2017
EKOBOT AB	Directeur Financier/CFO	01/01/2020
Brf Arken	Corporate Officer/Principal	-
Favro Holding AB	Directeur Général	-
LobSor International AB	Directeur/Membre du Conseil	-
HERAccount AB	Président	-
Balanced Competence Uppasala Redovisiningsbyra AB	Corporate Officer/Principal	-
Helander & Lundvik Ekonomikonsulter AB	Corporate Officer/Principal	-
Enable-Finance & Business Development AB	Directeur Général	01/01/2018

Anciens postes connus de Birgitta Lundvik

Sociétés	Poste	Fin
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░	░░░░░░░░░░	-
░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░	-
░░░░░ ░░░░░ ░░░░░░░░ ░░░░	░░░░░░░░░░░ ░░░░░░░░░	-
░░░░░ ░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░	-